We are committed to joining other healthcare stakeholders, government entities, civic organizations, law enforcement agencies and individuals to overcome this terrible tragedy.
Ensuring Safe and Secure Drug Distribution
AmerisourceBergen does not prescribe drugs, provide them directly to patients or take any action to drive demand for them. We transport medicine from manufacturers to licensed pharmacies, hospitals and other dispensaries.
Ensuing the safety and security of this process has always been paramount. To achieve this, we continuously evaluate, enhance, strengthen and expand the proven measures we have implemented to maintain the integrity of every order we ship. These processes include:
Maintaining Operational Integrity
AmerisourceBergen takes very seriously its neutrality as a distributor of controlled substances. As such, we:
Take no action whatsoever to market, promote or otherwise increase demand for opioids.
Do not offer our sales representatives special compensation or incentives of any kind that target opioid orders.
Continuously monitor all orders and immediately flag those deemed potentially suspicious.
Advocating for the Highest Regulatory Standards
Opioids are heavily regulated by the government; from the time they are produced to the time they are dispensed to patients. Every stakeholder in this process — the manufacturer, distributor, prescriber and dispenser — must strictly adhere to requirements outlined in the Federal Code of Regulations.
AmerisourceBergen enthusiastically endorses these guidelines and strongly advocates for the implementation of additional measures.
The AmerisourceBergen Foundation remains committed to providing communities with the resources needed to help prevent opioid abuse and misuse. We continue to evaluate how we can best leverage our unique resources to support initiatives or organizations that aim to address the nation’s opioid epidemic.